These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 23639973)
1. Retinoid acid receptor expression is helpful to distinguish between adenoma and well-differentiated carcinoma in the thyroid. Gauchotte G; Lacomme S; Brochin L; Tournier B; Cahn V; Monhoven N; Piard F; Klein M; Martinet N; Rochette-Egly C; Vignaud JM Virchows Arch; 2013 Jun; 462(6):619-32. PubMed ID: 23639973 [TBL] [Abstract][Full Text] [Related]
2. Retinoic acid receptor and retinoid X receptor subtype expression for the differential diagnosis of thyroid neoplasms. Hoftijzer HC; Liu YY; Morreau H; van Wezel T; Pereira AM; Corssmit EP; Romijn JA; Smit JW Eur J Endocrinol; 2009 Apr; 160(4):631-8. PubMed ID: 19155317 [TBL] [Abstract][Full Text] [Related]
3. Retinoid machinery in distinct neural stem cell populations with different retinoid responsiveness. Orsolits B; Borsy A; Madarász E; Mészáros Z; Kőhidi T; Markó K; Jelitai M; Welker E; Környei Z Stem Cells Dev; 2013 Oct; 22(20):2777-93. PubMed ID: 23734950 [TBL] [Abstract][Full Text] [Related]
4. DNA Methylation Haplotype Block Markers Efficiently Discriminate Follicular Thyroid Carcinoma from Follicular Adenoma. Zhang H; Zhang Z; Liu X; Duan H; Xiang T; He Q; Su Z; Wu H; Liang Z J Clin Endocrinol Metab; 2021 Mar; 106(4):1011-1021. PubMed ID: 33394038 [TBL] [Abstract][Full Text] [Related]
5. Molecular and metabolic retinoid pathways in the human ocular surface. Nezzar H; Chiambaretta F; Marceau G; Blanchon L; Faye B; Dechelotte P; Rigal D; Sapin V Mol Vis; 2007 Sep; 13():1641-50. PubMed ID: 17893666 [TBL] [Abstract][Full Text] [Related]
6. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation. Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180 [TBL] [Abstract][Full Text] [Related]
7. QPRT: a potential marker for follicular thyroid carcinoma including minimal invasive variant; a gene expression, RNA and immunohistochemical study. Hinsch N; Frank M; Döring C; Vorländer C; Hansmann ML BMC Cancer; 2009 Mar; 9():93. PubMed ID: 19321014 [TBL] [Abstract][Full Text] [Related]
8. RDH10, RALDH2, and CRABP2 are required components of PPARγ-directed ATRA synthesis and signaling in human dendritic cells. Gyöngyösi A; Szatmari I; Pap A; Dezso B; Pos Z; Széles L; Varga T; Nagy L J Lipid Res; 2013 Sep; 54(9):2458-74. PubMed ID: 23833249 [TBL] [Abstract][Full Text] [Related]
9. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies. Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010 [TBL] [Abstract][Full Text] [Related]
10. Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity. Stokowy T; Wojtas B; Jarzab B; Krohn K; Fredman D; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Paschke R; Eszlinger M Endocrine; 2016 Nov; 54(2):440-447. PubMed ID: 27473101 [TBL] [Abstract][Full Text] [Related]
11. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma. Tan A; Etit D; Bayol U; Altinel D; Tan S Ann Diagn Pathol; 2011 Apr; 15(2):108-16. PubMed ID: 21315633 [TBL] [Abstract][Full Text] [Related]
12. Both all-trans retinoic acid and cytochrome P450 (CYP26) inhibitors affect the expression of vitamin A metabolizing enzymes and retinoid biomarkers in organotypic epidermis. Pavez Loriè E; Chamcheu JC; Vahlquist A; Törmä H Arch Dermatol Res; 2009 Aug; 301(7):475-85. PubMed ID: 19294396 [TBL] [Abstract][Full Text] [Related]
13. Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer. Frisk T; Foukakis T; Dwight T; Lundberg J; Höög A; Wallin G; Eng C; Zedenius J; Larsson C Genes Chromosomes Cancer; 2002 Sep; 35(1):74-80. PubMed ID: 12203792 [TBL] [Abstract][Full Text] [Related]
14. Follicular Thyroid Neoplasms: Comparison of Clinicopathologic and Molecular Features of Atypical Adenomas and Follicular Thyroid Carcinomas. Cracolici V; Ritterhouse LL; Segal JP; Puranik R; Wanjari P; Kadri S; Parilla M; Cipriani NA Am J Surg Pathol; 2020 Jul; 44(7):881-892. PubMed ID: 32282345 [TBL] [Abstract][Full Text] [Related]
15. Differential loss of heterozygosity in the region of the Cowden locus within 10q22-23 in follicular thyroid adenomas and carcinomas. Marsh DJ; Zheng Z; Zedenius J; Kremer H; Padberg GW; Larsson C; Longy M; Eng C Cancer Res; 1997 Feb; 57(3):500-3. PubMed ID: 9012481 [TBL] [Abstract][Full Text] [Related]
16. High frequency of loss of heterozygosity in imprinted, compared with nonimprinted, genomic regions in follicular thyroid carcinomas and atypical adenomas. Sarquis MS; Weber F; Shen L; Broelsch CE; Jhiang SM; Zedenius J; Frilling A; Eng C J Clin Endocrinol Metab; 2006 Jan; 91(1):262-9. PubMed ID: 16249278 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of mir-129-1, miR-146b, mir-183, and mir-197 in follicular thyroid carcinoma and adenoma tissues. Sheikholeslami S; Shabani N; Shivaee S; Tavangar SM; Yeganeh M; Hedayati M; Lotfi J; Gholami H Mol Cell Probes; 2020 Jun; 51():101536. PubMed ID: 32081771 [TBL] [Abstract][Full Text] [Related]
18. [Loss of heterozygosity on chromosome 3p in thyroid tumors]. Hu MJ; Xu HD; Zhou R; Li XF; Zhang HY Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):305-8. PubMed ID: 18956647 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical separation of follicular variant of papillary thyroid carcinoma from follicular adenoma. Nakamura N; Erickson LA; Jin L; Kajita S; Zhang H; Qian X; Rumilla K; Lloyd RV Endocr Pathol; 2006; 17(3):213-23. PubMed ID: 17308358 [TBL] [Abstract][Full Text] [Related]
20. DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival. Mancikova V; Buj R; Castelblanco E; Inglada-Pérez L; Diez A; de Cubas AA; Curras-Freixes M; Maravall FX; Mauricio D; Matias-Guiu X; Puig-Domingo M; Capel I; Bella MR; Lerma E; Castella E; Reverter JL; Peinado MÁ; Jorda M; Robledo M Int J Cancer; 2014 Aug; 135(3):598-610. PubMed ID: 24382797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]